Field of research: Pharmaceutical nanotechnology
• Development of nanofibers with active pharmaceutical ingredients (API) and probiotics: development of monolithic and core-shell nanofibers by electrospinning, development of inorganic nanofibers.
• Development of nanoparticles and vesicles: the development of different nanodelivery systems, such as solid lipid nanoparticles, liposomes, ethosomes, transfers and DQAsomes, for transdermal delivery of API or targeted delivery.
• Evaluation of nanodelivery systems: evaluation of morphology of nanodelivery systems (scanning electron microscopy), release of API, solid-state characterization of API and excipients (differential dynamic calorimetry) and interactions between them (Fourier transformation infrared spectroscopy), the cultivation of probiotics, evaluation of the viability of probiotics after their incorporation and during storage, and the release of probiotics from the delivery system.
|